Capital intelligenceV1 · 2026Partial public coverage

BCI Funding Index

A screened view of who has financed 25 implanted and implant-adjacent BCI companies — with round history, investor participation, and regulatory inflection points on one plate.

25
selected companies
$3.55B
indexed financing · incl. commitments
42
sourced financings
15
regulatory markers
Company
2017201820192020202120222023202420252026
Indexed financing
Financing (width scales with disclosed amount)IDERegulatory marker25 of 25 companies
Screen

Selected implanted, minimally invasive, and implant-adjacent BCI companies with at least one publicly sourced financing of $2m or more.

Coverage

Publicly disclosed financing records, not an exhaustive funding-to-date or cash-receipts total. Explicitly labeled philanthropic commitments are included; combined multi-round disclosures are counted once without inventing an allocation. Backer participation and associated capital refer to the whole disclosed financing record, not check sizes. Dates distinguish announcements and reports from actual events; unestablished dates retain an unverified label. Amounts are source-reported financing values or sourced historical FX estimates. Legacy estimates with unresolved FX provenance remain explicitly qualified; pinned conversions are not revalued at current rates. Company histories and source-access coverage remain partial; standalone grants and lifetime cumulative totals are not added. Latest selective review Nov 17, 2026. Financing histories remain partial, and the indexed sum is not an all-time total.